David A Morilak

Professor, Pharmacology

Phone+1-210-567-4174
Emailmorilak@uthscsa.edu

Source: Scopus
Calculated based on no. of publications stored in Pure and citations from Scopus

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint

Dive into the research topics where David A Morilak is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

9 Similar Profiles

Network

Recent external collaboration on country level. Dive into details by clicking on the dots.

1 Active
2 Not started
6 Finished

CENTRAL ANF AND CARDIOVASCULAR REGULATION
Morilak, D. A.
National Institutes of Health
6/15/87 → …
Project: Research project
Cognitive impairment associated with androgen deprivation therapy for prostate cancer
Morilak, D. A.
Project: Research project
Treating PTSD and depression: Mechanisms of pharmacotherapy and psychotherapy in rats
Morilak, D. A. & Frazer, A.
Project: Research project
Integrated Graduate Training Program in Neuroscience, UTHSCSA
Morilak, D. A.
National Institutes of Health
7/1/13 → 6/30/18
Project: Research project
South Texas Advanced Research Training: Undergraduate Program (START-UP)
Frazer, A., Weiss, D. S. & Morilak, D. A.
National Institutes of Health
9/30/10 → 8/31/16
Project: Research project

5850 Citations
45 h-Index
84 Article
9 Review article
3 Chapter
1 Comment/debate
More
- 1 Editorial

Bidirectional optogenetically-induced plasticity of evoked responses in the rat medial prefrontal cortex can impair or enhance cognitive set-shifting
Bulin, S. E., Hohl, K. M., Paredes, D., Silva, J. D. & Morilak, D. A., Jan 1 2020, In: eNeuro. 7, 1, ENEURO.0363-19.2019.
Research output: Contribution to journal › Article › peer-review

Open Access
1 Scopus citations
A rodent model of exposure therapy: The use of fear extinction as a therapeutic intervention for PTSD
Paredes, D. & Morilak, D. A., Jan 30 2019, In: Frontiers in Behavioral Neuroscience. 13, 46.
Research output: Contribution to journal › Review article › peer-review

Open Access
5 Scopus citations
Ciliary neurotrophic factor signaling in the rat orbitofrontal cortex ameliorates stress-induced deficits in reversal learning
Girotti, M., Silva, J. D., George, C. M. & Morilak, D. A., Dec 1 2019, In: Neuropharmacology. 160, 107791.
Research output: Contribution to journal › Article › peer-review
Vortioxetine reverses medial prefrontal cortex-mediated cognitive deficits in male rats induced by castration as a model of androgen deprivation therapy for prostate cancer
Sharp, A. M., Lertphinyowong, S., Yee, S. S., Paredes, D., Gelfond, J., Johnson-Pais, T. L., Leach, R. J., Liss, M., Risinger, A. L., Sullivan, A. C., Thompson, I. M. & Morilak, D. A., Nov 1 2019, In: Psychopharmacology. 236, 11, p. 3183-3195 13 p.
Research output: Contribution to journal › Article › peer-review
2 Scopus citations
Activity in the ventral medial prefrontal cortex is necessary for the therapeutic effects of extinction in rats
Fucich, E. A., Paredes, D., Saunders, M. O. & Morilak, D. A., Feb 7 2018, In: Journal of Neuroscience. 38, 6, p. 1408-1417 10 p.
Research output: Contribution to journal › Article › peer-review
6 Scopus citations

University of Texas Health Science Center at San Antonio: Free Public Symposium Nov. 30 to Break Down Schizophrenia's Walls
David A Morilak, Daniel J Lodge & Dawn I Velligan
11/16/18
1 item of Media coverage
Press/Media: Press / Media
CPRIT Awards UT Health San Antonio Researcher Nearly $900,000 to Study Cognitive Impairment
David A Morilak
2/22/18
1 item of Media coverage
Press/Media: Press / Media